2009 annual financial data
Marker Therapeutics 2009 Operating margin
Marker Therapeutics 2009 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -4,193,438 USD and net income was -4,461,970 USD.
Operating cash flow was -1,121,726 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -4,193,438 USD
- Net income
- -4,461,970 USD
- Operating cash flow
- -1,121,726 USD